Damm-Welk, C.; Lovisa, F.; Contarini, G.; Lüdersen, J.; Carraro, E.; Knörr, F.; Förster, J.; Zimmermann, M.; Sala, A.; Vinti, L.;
et al. Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials? Cancers 2022, 14, 1703.
https://doi.org/10.3390/cancers14071703
AMA Style
Damm-Welk C, Lovisa F, Contarini G, Lüdersen J, Carraro E, Knörr F, Förster J, Zimmermann M, Sala A, Vinti L,
et al. Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials? Cancers. 2022; 14(7):1703.
https://doi.org/10.3390/cancers14071703
Chicago/Turabian Style
Damm-Welk, Christine, Federica Lovisa, Giorgia Contarini, Jette Lüdersen, Elisa Carraro, Fabian Knörr, Jan Förster, Martin Zimmermann, Alessandra Sala, Luciana Vinti,
and et al. 2022. "Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?" Cancers 14, no. 7: 1703.
https://doi.org/10.3390/cancers14071703
APA Style
Damm-Welk, C., Lovisa, F., Contarini, G., Lüdersen, J., Carraro, E., Knörr, F., Förster, J., Zimmermann, M., Sala, A., Vinti, L., Tondo, A., Pillon, M., Woessmann, W., & Mussolin, L.
(2022). Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials? Cancers, 14(7), 1703.
https://doi.org/10.3390/cancers14071703